PhosphaLine 4:1 By XYMOGEN Overview & Drug Interactions

Check For Interactions With PhosphaLine 4:1

Supplement: PhosphaLine 4:1 by XYMOGEN

PhosphaLine 4:1 Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with PhosphaLine 4:1 by XYMOGEN

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

There were no interactions found with PhosphaLine 4:1. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.


Still looking for more information about PhosphaLine 4:1 interactions? Ask Dr. Brian Staiger about it by contacting him directly.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
2 Softgel(s)
Maximum serving Sizes:
2 Softgel(s)
Servings per container 50

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Calories
9 {Calories}
Header
Calories from Fat
8 {Calories}
Header
Total Fat
0.9 Gram(s)
Fat (unspecified) 1.5%
Saturated Fat
0.2 Gram(s)
Saturated fat 1%
Polyunsaturated Fat
0.6 Gram(s)
Polyunsaturated Fat --
Monounsaturated Fat
0.11 Gram(s)
Monounsaturated Fat --
Phospholipid Complex
900 mg
Blend (Fatty Acid or Fat/Oil Supplement) --

Other Ingredients:
Phosphatidylcholine
Phosphatidylethanolamine
Phosphatidylinositol
minor Glycolipids
A Proprietary Blend of Essential Fatty Acids
Forms
  • Alpha-Linolenic Acid
  • Linoleic Acid
  • minor Fatty Acids
  • Oleic Acid
Ethanol
Gelatin


Label Statments:


Suggested/Recommended/Usage/Directions
- DIRECTIONS: Take two softgels daily, or as directed by your healthcare practitioner.
General Statements
- Phosphatidylcholine (PC) is perhaps the most important molecule among tens of thousands of molecules that comprise a cell. It makes up approximately 50% of the cell membrane, which holds the balance of life in every cell.
- Whereas many other PC formulas on the market contain an approximate ratios of 12:1 between omega 6 and omega 3 fatty acids, PhosphaLine 4:1 contains a 4:1 ratio, which has been endorsed as optimal by the World Health Organization.
- EXCLUSIVE PROFESSIONAL FORMULAS
- Complex with 4:1 Ratio of Omega 6 to Omega 3
- Pharmaceutical Grade Professional Use Only
- This package is completely recyclable
Brand IP Statement(s)
- The pure phospholipids in PhosphaLine 4:1(TM) form liposomes in the body's watery environment.
- (C) 2012 XYMOGEN
Precautions
- CAUTIONS: Consult your healthcare practitioner before use.
- Avoid if allergic to any ingredient.
- Keep out of reach of children.
Storage
- STORAGE: Keep tightly closed in a dry place at controlled room temperatures 15(0)-30(0)C (59(0)-86(0)F).
Formulation
- DOES NOT CONTAIN: Wheat, gluten, corn protein, yeast, soy protein, dairy products, fish, shellfish, peanuts, tree nuts, egg, artificial colors, artificial sweeteners, or preservatives.
FDA Statement of Identity
- Dietary Supplement
General
- REV. 032912

Brand Information

See all products by this brand

Researched & Distributed by:
Name XYMOGEN Exclusive Professional Formulas
Street Address 6900 Kingspointe Pkwy.
City Orlando
State FL
ZipCode 32819
Phone Number 800-647-6100
Web Address www.xymogen.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.